months
partners
countries
mio.
The IFIGENEIA project addresses the challenges of modern nuclear medicine by introducing advanced LINAC (Linear Accelerator) technology as a sustainable and environmentally friendly alternative to traditional radioisotope production sources. The project will establish three Excellence Hubs in Greece, Slovenia, and Cyprus, serving as innovation centers for the development, validation, and commercialization of radioisotopes and related technologies. The main goal is to support research, diagnostics, therapy, and theranostics by utilizing LINAC technology, which enables high flexibility, safety, and accessibility. Each Hub brings together key stakeholders from research, industry, public sector, and civil society in a quadruple-helix model, while aligning with regional RIS3 strategies. In addition to the technological dimension, the project includes the development of investment strategies, the strengthening of entrepreneurial skills, and mentoring activities for Western Balkan countries, with the aim of fostering long-term European integration and knowledge transfer.
Project Overwiev
Project title:
Innovative Facility for Isotope GENeration with Efficient Ion Accelerator
Acronym:
IFIGENEIA
Programme:
Horizon Europe – WIDERA-2023-ACCESS-07
Action Type:
CSA – Coordination and Support Action
Duration:
March 2025 – February 2029 (48 months)
Total Budget:
€6,000,000
Coordinator:
Aristotle University of Thessaloniki (AUTH), Greece
Project motto:
Scientific knowledge for the health of tomorrow
The IFIGENEIA project addresses the challenges of modern nuclear medicine by introducing advanced LINAC (Linear Accelerator) technology as a sustainable and environmentally friendly alternative to traditional radioisotope production sources. The project will establish three Excellence Hubs in Greece, Slovenia, and Cyprus, serving as innovation centers for the development, validation, and commercialization of radioisotopes and related technologies. The main goal is to support research, diagnostics, therapy, and theranostics by utilizing LINAC technology, which enables high flexibility, safety, and accessibility. Each Hub brings together key stakeholders from research, industry, public sector, and civil society in a quadruple-helix model, while aligning with regional RIS3 strategies. In addition to the technological dimension, the project includes the development of investment strategies, the strengthening of entrepreneurial skills, and mentoring activities for Western Balkan countries, with the aim of fostering long-term European integration and knowledge transfer.
Project Overwiev
Project title:
Innovative Facility for Isotope GENeration with Efficient Ion Accelerator
Acronym:
IFIGENEIA
Programme:
Horizon Europe – WIDERA-2023-ACCESS-07
Action Type:
CSA – Coordination and Support Action
Duration:
March 2025 – February 2029 (48 months)
Total Budget:
€6,000,000
Coordinator:
Aristotle University of Thessaloniki (AUTH), Greece
Project motto:
Knowledge and science for the health of tomorrow
Vision and Objectives
Develop a comprehensive design and business plan for a LINAC-based facility
Enable sustainable, tunable production of medical radioisotopes
Establish regional Excellence Hubs in Greece, Slovenia, and Cyprus
Foster interregional cooperation in nuclear medicine and related sectors
Mentor and prepare future hubs in Western Balkan countries
Geographical Focus
Together, we are establishing a sustainable platform for radiopharmaceutical production, training, and innovation across the Balkans and Europe.
Main Hubs
Greece LINAC design, Beam dynamic studies, Beam parameters and HW specifications, Safety and radiation protection requirements, Small scale LINAC prototype, Pilot in health and culture.
Slovenia Controls, Lab condition development, Isotopes identification, Ligands investigation, Pilot pre-clinical studies.
Cyprus Exploitation Strategies, Business Plan, Investment Plan, Private Equity.
Mentorship for Western Balkans
Bosnia and Herzegovina Support for future excellence hubs: Mentoring activities, Knowledge transfer.
International collaboration
CERN, DKFZ, GSI Ensuring scientific excellence and regional impact.
Geographical Focus
Together, we are establishing a sustainable platform for radiopharmaceutical production, training, and innovation across the Balkans and Europe.
Main Hubs
Greece LINAC design, Beam dynamic studies, Beam parameters and HW specifications, Safety and radiation protection requirements, Small scale LINAC prototype, Pilot in health and culture.
Slovenia Controls, Lab condition development, Isotopes identification, Ligands investigation, Pilot pre-clinical studies.
Cyprus Exploitation Strategies, Business Plan, Investment Plan, Private Equity.
Mentorship for Western Balkans
Bosnia and Herzegovina Support for future excellence hubs: Mentoring activities, Knowledge transfer.
International collaboration
CERN, DKFZ, GSI Ensuring scientific excellence and regional impact.
Work Packages
Project management
Education, Dissemination, Inclusion and Diversity
Leader: Jožef Stefan Institute
LINAC design dedicated to radioisotope production and other societal applications
Radioisotope production and radiopharmaceuticals
Leader: University of Ljubljana
Business plan for end users: From science to business including spinoffs
Leader: RTD TALOS Limited
Mentorship
Leader: University of Cyprus
Work Packages
Project management
Education, Dissemination, Inclusion and Diversity
Leader: Jožef Stefan Institute
LINAC design dedicated to radioisotope production and other societal applications
Radioisotope production and radiopharmaceuticals
Leader: University of Ljubljana
Business plan for end users: From science to business including spinoffs
Leader: RTD TALOS Limited
Mentorship
Leader: University of Cyprus
Partners
Partners
